According to a report in Europe, a Paris, France, court found that Medtrum’s latest insulin pumps infringe an Insulet (Nasdaq:PODD) patent.
JUVE Patent reported that earlier this month, the Judicial Court of Paris declared the infringement. The court found that Medtrum’s newest pump base and patch reservoir models violate the EP2438957B1 patent from Insulet.
In declaring the infringement, the court ordered Medtrum to recall its Nano TouchCare pumps sold in France. Patients already using the device received an exemption.
Get the full story at our sister site, Drug Delivery Business News.